Key result
miR-505-5p overexpression reduces ischemia-reperfusion myocardial apoptosis and inflammation by inhibiting serum uromodulin.
Why the study?
Little research has analyzed the role and molecular mechanism of miR-505-5p in myocardial injury caused by ischemia-reperfusion.
Does miR-505-5p overexpression reduce myocardial apoptosis and inflammation in ischemia-reperfusion injury?
Does miR-505-5p overexpression reduce myocardial apoptosis and inflammation in ischemia-reperfusion injury?
miR-505-5p ameliorates myocardial ischemia-reperfusion injury by inhibiting serum uromodulin, thereby reducing apoptosis and inflammation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rodent ischemia-reperfusion injury; leaves open clinical translation of miR-505-5p modulation.
Background. It has been found that miR‐505‐5p is closely related to cardiovascular metabolic risk factors. Nonetheless, there is little research analyzing miR‐505‐5p for its role as well as molecular mechanism in myocardial injury caused by ischemia‐reperfusion (I/R). Methods. This work utilized quantitative reverse transcriptase PCR (qRT‐PCR) for detecting miR‐505‐5p and serum uromodulin (sUmod) levels. sUmod, interleukin‐1beta (IL‐1β), IL‐6, IL‐10, caspase7, caspase9, tumor necrosis factor‐alpha (TNF‐α), Bax, and Bcl‐xL expression was detected by western blot. Bioinformatics database was used for target prediction and miR‐505‐5’s target was determined by luciferase reporter gene assay. Results. Relative to sham group, sUmod was highly expressed within myocardial I/R injury (MIRI), whereas sUmod silencing significantly decreased the heart weight/body weight ratio, reduced serum myocardial enzymes expression, ameliorated I/R‐mediated myocardial apoptosis, and inflammation. TargetScan bioinformatics database and luciferase reporter genes confirmed that sUmod was miR‐505‐5p’s direct target gene, besides, miR‐505‐5p overexpression significantly improved the myocardial injury score, increased IL‐10, decreased TNF‐α, IL‐1β, IL‐6 expression, decreased caspase7, caspase9, Bax expression, and increased Bcl‐xL expression. More importantly, overexpression of sUmod abolished miR‐505‐5p overexpression’s role in I/R‐mediated myocardial apoptosis and inflammation. Conclusion. miR‐505‐5p can improve I/R‐mediated myocardial apoptosis and inflammation by targeting sUmod. In this study, miR‐505‐5p is related to MIRI pathogenesis, which provides the new possible targeted therapy in patients with MIRI.
No takes yet. Share an insight, caveat, or question.
He et al. (2022) studied Myocardial ischemia-reperfusion injury. miR-505-5p overexpression and sUmod silencing vs. Sham group was evaluated on Myocardial apoptosis and inflammation. Overexpression of miR-505-5p ameliorated ischemia-reperfusion-mediated myocardial apoptosis and inflammation by directly targeting and inhibiting serum uromodulin.
Synapse has enriched 10 related papers. Consider them for comparative context: